Severe persistent visual field constriction associated with vigabatrin.
Eke
T
T
Department of Ophthalmology, Leicester Royal Infirmary.
Talbot
J F
JF
Lawden
M C
MC
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors*; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020888:Vigabatrin; D014786:Vision Disorders / Q000139:chemically induced*; D014794:Visual Fields; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin